Form 4: Procter & Gamble CEO Beauty, Alexandra Keith, Reports Sale of Common Stock

Sentiment:

SEC Form 4 Filing


Alexandra Keith, CEO Beauty at Procter & Gamble, reported the sale of 855 shares of common stock at $158.50 on April 22, 2024.

Summary

  • Alexandra Keith, CEO Beauty at Procter & Gamble, filed a Form 4 on April 23, 2024, reporting a transaction involving the company's common stock.
  • On April 22, 2024, Keith sold 855 shares of common stock at a price of $158.50 per share.
  • Following the transaction, Keith directly owns 24,736.4375 shares of common stock.
  • Keith also indirectly owns 4,003.5522 shares through a spouse, 4,137.1526 shares through a retirement plan trustee, and 7,525.0066 shares through a spouse and retirement plan trustee.
  • The reported holdings reflect adjustments to the Performance Stock Target (PST) through March 31, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine stock sale by an executive, which doesn't inherently indicate positive or negative performance for the company.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates a sale of shares by a key executive, which could be for personal financial management reasons.

Stakeholder Impact

  • The stock sale may have a minor impact on shareholders, depending on their interpretation of insider trading activity.

Key Dates

DateDescription
03/31/2024Date through which PST adjustments are reflected
04/22/2024Date of stock sale transaction
04/23/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.